QQ客服 官方微博 反馈留言

	Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer.
	Yanpeng Xiong; Liang Zhou; Zijie Su; Jiaxing Song; Qi Sun; Shan-Shan Liu; Yuqing Xia; Zhongyuan Wang; Desheng Lu
刊名	OncoTargets and therapy
	2019
卷号	Vol.12页码:993-1005
关键词	CK1δ CK1ε Wnt breast cancer longdaysin β-catenin signaling
ISSN号	1178-6930
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4745861
专题	湖南大学
作者单位	1.Guangdong Key Laboratory for Genome Stability and Disease Prevention, Shenzhen University International Cancer Center, Department of Pharmacology, Shenzhen University Health Science Center, Shenzhen 518060, Guangdong, China, wangzhongyuan@szu.edu.cn 2.delu@szu.edu.cn.
推荐引用方式 GB/T 7714	Yanpeng Xiong,Liang Zhou,Zijie Su,et al. Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer.[J]. OncoTargets and therapy,2019,Vol.12:993-1005.
APA	Yanpeng Xiong.,Liang Zhou.,Zijie Su.,Jiaxing Song.,Qi Sun.,...&Desheng Lu.(2019).Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer..OncoTargets and therapy,Vol.12,993-1005.
MLA	Yanpeng Xiong,et al."Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer.".OncoTargets and therapy Vol.12(2019):993-1005.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。